Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP753078.RAng5BxLow3ribiYdMqVT_T5qBQ_4ffkgkBD90eVBbLxo130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP753078.RAng5BxLow3ribiYdMqVT_T5qBQ_4ffkgkBD90eVBbLxo130_provenance.
• NP569900.RAxGnI2CgHMWuYXLTft2e1sZnb0socsxvl1lGvNhGJCKk130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP569900.RAxGnI2CgHMWuYXLTft2e1sZnb0socsxvl1lGvNhGJCKk130_provenance.
• NP917241.RAh3ywZBTZ6eaf3MOt5q3c_z2TH5PGFzcEiqB7eYv3X7M130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917241.RAh3ywZBTZ6eaf3MOt5q3c_z2TH5PGFzcEiqB7eYv3X7M130_provenance.
• NP164216.RAE7DkZhd8SMWnm-9OADtjjaVMSolcBadumweahS40dqQ130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164216.RAE7DkZhd8SMWnm-9OADtjjaVMSolcBadumweahS40dqQ130_provenance.
• NP898008.RA2s6xzmpFJWH0vpvYUZCTG7p291YHINckUWIhKD9NvNo130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP898008.RA2s6xzmpFJWH0vpvYUZCTG7p291YHINckUWIhKD9NvNo130_provenance.
• assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP610087.RAa-4Y4ZneLCR6PW38oGqEnZpFu-clIta5YdEXeiLDlcA130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610087.RAa-4Y4ZneLCR6PW38oGqEnZpFu-clIta5YdEXeiLDlcA130_provenance.
• NP718886.RAFW_pu5B6VE4Npla8kajvhzMhRvJK8TGPiyJglcytbaA130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718886.RAFW_pu5B6VE4Npla8kajvhzMhRvJK8TGPiyJglcytbaA130_provenance.
• NP739378.RAkk0e4E5KO2YhEymZbfCqqteZiMxIJZMh7u_GvyuqYtk130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739378.RAkk0e4E5KO2YhEymZbfCqqteZiMxIJZMh7u_GvyuqYtk130_provenance.
• NP610085.RAipmGRBPvySKqKIOCUd4qnHn9K5jezuF9-jzRgn2FV88130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610085.RAipmGRBPvySKqKIOCUd4qnHn9K5jezuF9-jzRgn2FV88130_provenance.
• NP610091.RAtk7iaS9hIV4w9pYaETnBO0ae80mWj_UqHa0AtGWS-HA130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610091.RAtk7iaS9hIV4w9pYaETnBO0ae80mWj_UqHa0AtGWS-HA130_provenance.
• NP739172.RAN7QVo0yzeMrNeRVxd2O3sPlBYvM5O8UMGJ3Y6PtuJVU130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739172.RAN7QVo0yzeMrNeRVxd2O3sPlBYvM5O8UMGJ3Y6PtuJVU130_provenance.
• NP610090.RAO-gSRiRAOT25_v7BJDtdLvzRGNPJ9y13xdz6tFiWbjY130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610090.RAO-gSRiRAOT25_v7BJDtdLvzRGNPJ9y13xdz6tFiWbjY130_provenance.
• NP739455.RA06tykgnCoOE11YWtdm_X9kWrLIoR6W2JXtlNgeiMhhM130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739455.RA06tykgnCoOE11YWtdm_X9kWrLIoR6W2JXtlNgeiMhhM130_provenance.
• NP610086.RA9OE7Ln4x1X_hrduASWEZ6oDbhxHEb6pICrD0X5EveR4130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610086.RA9OE7Ln4x1X_hrduASWEZ6oDbhxHEb6pICrD0X5EveR4130_provenance.
• NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_assertion description "[SESN3, TITF1 and MLH1 methylation did not predict overall survival or disease-free survival in this large cohort of patients with endometrioid endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP610092.RAwlUPqoIwEq-XVH9jJjmF04aWD11OOlljc5TLjqt5wh4130_provenance.